CannaPharmaRx Inc
CannaPharmaRX, Inc. engages in acquisition, development, and operation of cannabis cultivation facilities in Canada. It produces and sells dried cannabis flower. The company is based in Calgary, Canada.
CannaPharmaRx Inc (CPMD) - Total Liabilities
Latest total liabilities as of September 2025: $34.13 Million USD
Based on the latest financial reports, CannaPharmaRx Inc (CPMD) has total liabilities worth $34.13 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
CannaPharmaRx Inc - Total Liabilities Trend (1998–2024)
This chart illustrates how CannaPharmaRx Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
CannaPharmaRx Inc Competitors by Total Liabilities
The table below lists competitors of CannaPharmaRx Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
PT Hetzer Medical Indonesia Tb
JK:MEDS
|
Indonesia | Rp11.74 Billion |
|
Lilium N.V.
PINK:LILWF
|
USA | $280.49 Million |
|
Pearl Gull Iron Ltd
AU:PLG
|
Australia | AU$7.93 Million |
|
Lakshmi Finance & Industrial Corporation Limited
NSE:LFIC
|
India | ₹33.44 Million |
|
OSI SYSTEMS
MU:OS2
|
Germany | €1.33 Billion |
|
AIR PROD.&CHEMICALS
MU:AP3
|
Germany | €20.29 Billion |
|
Menteng Heritage Realty Tbk PT
JK:HRME
|
Indonesia | Rp277.10 Billion |
|
Park & Bellheimer AG
F:PKB
|
Germany | €23.21 Million |
Liability Composition Analysis (1998–2024)
This chart breaks down CannaPharmaRx Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.52 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 2.94 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CannaPharmaRx Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CannaPharmaRx Inc (1998–2024)
The table below shows the annual total liabilities of CannaPharmaRx Inc from 1998 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $30.65 Million | +28.23% |
| 2023-12-31 | $23.90 Million | +5.01% |
| 2022-12-31 | $22.76 Million | +74.53% |
| 2021-12-31 | $13.04 Million | -25.69% |
| 2020-12-31 | $17.55 Million | +57.21% |
| 2019-12-31 | $11.16 Million | +1057.65% |
| 2018-12-31 | $964.30K | 0.00% |
| 2017-12-31 | $964.30K | +0.52% |
| 2016-12-31 | $959.33K | +37.72% |
| 2015-12-31 | $696.60K | -66.59% |
| 2014-12-31 | $2.09 Million | +614.05% |
| 2013-12-31 | $292.03K | +47.75% |
| 2012-12-31 | $197.65K | +98.47% |
| 2011-12-31 | $99.59K | -82.72% |
| 2009-12-31 | $576.30K | -15.89% |
| 2008-12-31 | $685.17K | +15.90% |
| 2007-12-31 | $591.18K | -92.56% |
| 2006-12-31 | $7.95 Million | +227.00% |
| 1999-12-31 | $2.43 Million | +737.93% |
| 1998-12-31 | $290.00K | -- |